SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-19-000797
Filing Date
2019-09-05
Accepted
2019-09-05 16:07:51
Documents
8
Period of Report
2019-09-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e618637_8k-immunic.htm 8-K 27799
2 e618637_ex10-1.htm EX-10.1 64904
3 e618637_ex10-2.htm EX-10.2 64404
4 e618637_ex99-1.htm EX-99.1 18013
5 e618637_ex99-2.htm EX-99.2 68227
6 e618637_ex99-3.htm EX-99.3 157019
7 e618637_ex99-4.htm EX-99.4 63726
8 GRAPHIC logo.jpg GRAPHIC 4663
  Complete submission text file 0001193805-19-000797.txt   471959
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 191077274
SIC: 2834 Pharmaceutical Preparations